1/78
Looks like no tags are added yet.
pulmonary embolism general info
common fatal condition DO NOT MISS
presentation variable
due to obstruction of pulmonary artery or one of it’s branches by material that originated elsewhere (thrombus, tumor, fat, embolus most common)
pulmonary embolism etiology
200,000 - 2 million dx per year with PE
2x that dx with DVT
increasing incidence in children and adolescence
1/3 cases attributable to hospitalization
what is the leading cause of hospital preventable death
pulmonary embolism
pulmonary embolism terminology
can be blood clot, fat, amniotic fluid, FB, septic emboli, tumor cells
DVT terminology
thrombosis in the legs, arms, or pelvis, from jugular vein or IVC
venous thromboembolism terminology
PE or DVT
acute massive PE
hypotension (<90 or drop of SBP > 40 from baseline for > 15 mins)
elevated central venous pressure/neck vein distention
saddle embolism
acute PE that lodges at bifurcation of main pulmonary artery into left and right pulmonary arteries
25% mortality rate
provoked pathophysiology of PE
occur after triggering condition
surgery, trauma, limb or body immobility, disease that increases clotting risk
pregnancy, cancer, estrogen use, > 50
unprovoked pathophys of PE
no underlying risk factor
15% of recurrence in the next year
PE risk factors
virchows triad:
venous stasis
injury to vessel wall
hypercoagulability
central venous instrumentation/surgery within past 3 months
pregnancy
obesity
long air travel > 4 hours
smoking
factor V leiden
most PEs are from thrombi where
lower extremities - popliteal vein
exam: enlarged calf circumference, redness, palpable tendon, Homan’s sign
sx of smaller PE that traveled distally
local reaction irritates pain receptors in parietal pleura
chest pain
decreased RV outflow
right sided heart failure
peripheral edema, liver congestion
inflammatory mediator release of PE results in what sx
atelectasis, surfactant dysfunction, V/Q mismatch
dyspnea
respiratory alkalosis (pH > 7.45, PaCO2 < 35-40mmHg)
PE respiratory sx
hyperventilation
reflex bronchoconstriction
wheezing, increased work of breathing
PE heart sx
hypotension
decreased CO, RV outflow impeded, LV preload reduced
PE signs and sx
tachypnea
tachycardia
dyspnea
pleuritic chest pain
cough
pulse ox < 95%
wheezing
accentuated pulmonic S2 due to RV overload
JVD, RV failure
calf/thigh pain and swelling (Homan’s)
PE dx
CXR: most normal, sometimes cardiomegaly
ABG: hypoxemia, hypocapnia, respiratory alkalosis
unexplained hypoxia in presence of normal CXR
serum troponin I and T: elevated, indicates cardiac strain
PE d-dimer (poor specificity)
degredation of cross linked fibrin
measured by ELISA
level above 500 is abnormal
< 500 is strong evidence AGAINST PE
PE ECG
sinus tachycardia is most common
nonspecific ST segment and T wave changes
V1-V4 T wave inversions
poor prognosis if atrial fibrillation, RBBB, inferior Q waves, T wave inversion and/or ST segment changes
SI Q3 T3 pattern = right heart strain pattern
PE V/Q scan
first get CXR: must be normal
reported as probability
high clinical suspicion + high probability V/Q = 95% PE
low clinical suspicion + low probability V/Q = 4% PE
normal V/Q scan excludes PE
PE LE venous ultrasound
assess compressibility of vessel
test of choice to detect proximal DVT
gold standard and study of choice for PE dx
pulmonary angiography = gold standard
invasive, less accurate than CTPA, can provide therapeutics
CTPA (helical CT chest pulmonary angiogram)
study of choice!
non-invasive, sensitive and specific for PE
Clinical pretests for PE dx in ED
wells criteria
PERC criteria
wells criteria scoring
low <2
moderate 2-6
high >6
PERC criteria
wells score of < 2 who meet all of following criteria, PE is excluded, monitor off anticoagulation and search for diff dx
age <50 years
HR < 100bpm
oxyhemoglobin sat > 95%
no hx VTE
no recent trauma/surgery
no hemoptysis
no estrogen therapy
no unilateral leg swelling
steps to dx PE
pt has physiologic manifestation of PE (chest pain, abnormal vital sign)
Wells
low wells → PERC, if perc neg PE excluded, if perc + → d dimer (d dimer < 500 excluded, d dimer > 5-00 CT PE)
med wells 2-6 → d dimer
high wells >6 → CT
PE tx anticoagulation therapy
anticoagulant for 3-12 months
bleeding is major complication
use HESTIA and SPESI to determine inpatient or outpatient
determines home treatment of PE
HESTIA
provides 30 day mortality risk of PE
SPESI
SPESI
low risk pts for outpt tx
if 0, low risk mortality
if >1, high risk of mortality
SPESI criteria
age >80
hx cancer
hx chronic cardiopulmonary disease
pulse rate >110
SBP <100
SO2: <90%
Hestia criteria
SBP > 100
no thrombolysis needed
no active bleeding
SPO2 > 94% on room air
not already anticoagulated
no more than two doses of IV narcotics in ED
absence of other medical or social reasons to admit
creatine clearance >30mL/min
not pregnant, no severe liver disease
anticoagulation options for PE tx
unfractionated heparin (UFH)
low molecular weight heparin (LMWH)
direct factor Xa inhibitors prevent Xa from cleaving prothrombin → thrombin
vitamin K antagonists (warfarin)
how does heparin work
binds to and accelerates antithrombin to inactive clotting factors
inhibits additional thrombus formation
allows endogenous fibrinolytic mechanisms to lyse existing clot
not exogenous clot buster
heparin considerations
unfractionated heparin for pregnancy or if patient has planned procedure
given IV, bolus + infusion
follow aPTT (1.5-2.5x)
LMWH for cancer given SC, no labs to follow
warfarin tx of PE
start on same day as heparin initiation
starting dose is 5mg/day for 2 days then adjust
start w heparin and overlap for ~5 days
follow INR - therapeutic level is 2-3
many drug and food interactions with warfarin
when to use warfarin vitamin K antagonist
prosthetic heart valves
direct Xa inhibitors (apixaban, rivaroxaban), high risk of valve thrombosis
renal impairment
GI disease
cost
antiphospholipid syndrome
foods that affect warfarin
kale, spinach, brussel sprouts, parsley, collard greens, mustard greens, endive, red cabbage, green lettuce, chard
avoid drinking:
green tea, grapefruit juice, cranberry juice, alcohol
for PE, anticoagulation tx factor Xa inhibitors are
preferred!
DOACs: rivaroxaban and apixaban
use as monotherapy without heparin
lower bleeding risk than warfarin
cannot use rivaroxaban if creatine clearance < 30mL / min
hemodynamically stable inpatient tx for PE
supplemental oxygen
inpatient LMWH or IV heparin followed by oral anticoagulant
hemodynamically unstable inpatient PE tx
supplemental oxygen
IV fluids to improve preload and correct hypotension
IV heparin
thrombolysis
stable vitals, normal oxygen sat outpatient tx of PE
apixaban
rivaroxaban
edoxaban
pt without cancer anticoagulation tx of PE
primary/unprovoked: oral anticoagulation for. >3mo
secondary/provoked: discontinuation of anticoagulation is recommended after 3 mo
pt with cancer anticoagulation tx of PE
extended tx of LMWH is recommended
follow up for PE
2 weeks to 3 mo after diagnosis
chronic thromboembolic pulmonary hypertension (CTEPH)
in sx patients with persistent V/Q mismatch, abnormal TTE, or 6MWT (6 minute walk test) @ 3 months, refer for workup
prevention of PE
prophylaxis with medications or early ambulation
intermittent compression devices
elastic compression stockings
pneumothorax general info
free air in pleural cavity causing partial or complete lung collapse
types: spontaneous primary or secondary
traumatic: tension, iatrogenic
primary spontaneous pneumothorax general info
without precipitating event with no underlying pulmonary disease
result of ruptured apical bleb - air between lung and visceral pleura
occurs in thin tall boys and men <40, at rest, high altitude flying/diving
smoking, family hx, marfan are risk factors
secondary spontaneous pneumothorax info
occurs as complication of lung disease
COPD - smoking
asthma
cystic fibrosis
TB
pneumocystis pneumonia
interstitial lung disease
pneumothorax presentation
sudden onset chest pain and dyspnea
can resolve in 24 hours, occur at rest
hypoxemia
pneumothorax PE findings
decreased chest expansion on affected side
decreased breath sounds
hyperresonance to percussion
decreased or absent tactile fremitus
pneumothorax dx
CXR: upright 50mL air visible at apex
supine: deep sulcus sign
ultrasound used in ED
CT: most accurate dx
stable vs unstable pneumothorax eval
vital signs within normal limits
RR < 24
HR <120 and > 60
normal BP
RA sat >90%
speaking in whole sentences
any out of limits = unstable
primary pneumothorax tx
oxygen
unstable or recurrent: catheter or chest tube
stable: no SOB, observation for 6 hours, repeat chest x-ray 12-48 hours
+SOB = pig tail catheter
secondary pneumothorax tx
oxygen
small: pt stable, < 2cm, asx minimal
O2 for 6 hours, observe
moderate sx: catheter or tube thoracostomy and admission
small and sx or large > 2cm
catheter aspiration or chest tube via thoracostomy and admission
follow up of pneumothorax
ask abt sx improvement
ask abt genetic disorders or other sx
optimize underlying lung disease
advise smoking cessation
CONTRAINDICATION TO FLYING 1-3 WEEKS, SCUBA FOR LIFE
avoid contact sports x 2 weeks
when is surgery indicated for pneumothorax
recurrence, chemical pleurodesis
30% spontaneous pneumo recurrence risk
50% secondary pneumo recurrence risk
parapneumonic effusion general info
pleural effusion that forms in pleural space adjacent to pneumonia
20% of ppl with pneumonia develop parapneumonic effusion
exudate
empyema definition
purulent material collected in the effusion (pus)
can occur via infiltration from pneumonia bacteria or direct inoculation (chest tube)
can have loculations
parapneumonic effusion simple/complicated
simple/uncomplicated = sterile and free flowing
complicated = infection with bacteria, no pus, can have loculations
empyema risk factors
poor dental hygiene, malnutrition, alcohol drug abuse
immunosuppression < 18, > 65 years
GERD
preexisting pleural fluid
empyema most common pathogens
community acquired: strep species
significant alcohol abuse, GERD, DM: gram negatives
hospital acquired: staph aureus, pseudomonas
stages of parapneumonic empyema
1: uncomplicated, free flowing fluid
2: complicated effusion/empyema - fibrinopurulent/loculations
3: chronic: peel that encases lung, hindering lung fx, fluid cannot be withdrawn
parapneumonic effusion stage 1 values
LDH > 0.6
protein > 0.5
elev WBC neutrophil
normal pH
normal glucose
no bacteria
parapneumonic effusion stage 2 and 3 values
stage 2 - fibrinopurulent values
LDH >1000
elevated protein and WBC
pH <7.2
glucose <2.2
bacteria invade, fibrin deposits, loculations, + culture
stage 3 you cannot collect for labs
empyema without pneumonia bacterial invasion from:
esophageal rupture
chest trauma
hematogenous spread
carcinoma that breaches pleura
liver or spine infections
post surg
empyema sx
cough, fever, pleuritic chest pain, dyspnea, sputum production
insidious in onset/duration
PE: dull on percussion, decreased breath sounds, decreased vocal fremitus
empyema labs
CBC: elevated WBC, left shift (immature neutrophils high), decrease lymphocytes, elevated CRP, + culture
CMP
empyema dx
CXR, US, CT
thoracentesis
pus fluid
pleural fluid analysis
send for cell count and chemistries
cytology (gram stain and culture)
pleural effusion/empyema tx
uncomplicated effusion: abx for pneumonia
complicated effusion: drainage
empyema:
chest tube drainage, surgical drainage (VATS), IV abx, hospitalization
complicated effusions and empyema use abx AND drainage if
pleural fluid < 7.2 or glucose <40
+pleural fluid gram stain/culture
loculated/septated pleural effusion
large free flowing effusion > 0.5 hemithorax
effusion associated with thickened parietal pleura
sepsis from pleural source
pulmonary edema general info
fluid in the lungs
abnormal accumulation in lung parenchyma = diminished gas exchange = resp failure
pulmonary edema etiology
cardiogenic: cardiomyopathies, MI
noncardiogenic: ARDS, pneumonia, inhalation injury, pancreatitis leading to sepsis
feature of other diseases
pathophys of pulmonary edema
increase in intravascular hydrostatic pressures
endothelial injury
decrease in oncotic pressures due to hepatic, renal or nutritional protein losing states
pulmonary edema sx
SOB, PND, peripheral edema, inciting event
resp distress
pink frothy sputum cough
bilateral or unilateral crackles
increased respiratory effort/tachypnea/tachycardia
elevated JVP, peripheral edema, cardiac murmur
CXR pulmonary edema
alveolar opacification/batwinging
kerley B lines
cardiomegaly
diffuse interstitial thickening and cephalization
effusions
pulmonary edema dx workup
BNP
troponin
albumin level
CXR
ECG, lung US
lipase, LFT, toxicology
pulmonary edema tx
diuretics: furosemide
vasodilators: nitroglycerine (use if SBP > 110)
vent support: CPAP or BIPAP, intubation
tx underlying condition